In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Bausch Health Companies Inc (NYSE: BHC) was $5.91 for the day, down -10.05% from the previous closing price of $6.57. In other words, the price has decreased by -$10.05 from its previous closing price. On the day, 7.96 million shares were traded. BHC stock price reached its highest trading level at $6.24 during the session, while it also had its lowest trading level at $5.86.
Ratios:
Our analysis of BHC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.97. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.30.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $8.
On August 02, 2024, Piper Sandler Downgraded its rating to Underweight which previously was Neutral and also lowered its target price recommendation from $9 to $3.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.Raymond James initiated its Mkt Perform rating on July 10, 2024, with a $8 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’25 when PAULSON & CO. INC. bought 2,500,000 shares for $6.25 per share. The transaction valued at 15,625,000 led to the insider holds 73,255,869 shares of the business.
Carson Seana sold 13,370 shares of BHC for $97,735 on Sep 08 ’25. The EVP, General Counsel now owns 499,585 shares after completing the transaction at $7.31 per share. On Sep 08 ’25, another insider, Carson Seana, who serves as the Officer of the company, bought 13,370 shares for $7.31 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2192312832 and an Enterprise Value of 22844755968. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.10, and their Forward P/E ratio for the next fiscal year is 1.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20. Its current Enterprise Value per Revenue stands at 2.278 whereas that against EBITDA is 6.952.
Stock Price History:
The Beta on a monthly basis for BHC is 0.42, which has changed by -0.23938227 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $8.69, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is -14.05%, while the 200-Day Moving Average is calculated to be -5.91%.
Shares Statistics:
BHC traded an average of 2.58M shares per day over the past three months and 2362860 shares per day over the past ten days. A total of 370.47M shares are outstanding, with a floating share count of 328.12M. Insiders hold about 11.44% of the company’s shares, while institutions hold 69.32% stake in the company. Shares short for BHC as of 1767139200 were 4835516 with a Short Ratio of 1.88, compared to 1764288000 on 5649348. Therefore, it implies a Short% of Shares Outstanding of 4835516 and a Short% of Float of 1.4099999.
Earnings Estimates
The market rating for Bausch Health Companies Inc (BHC) is a result of the insights provided by 6.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.7, with high estimates of $0.84 and low estimates of $0.51.
Analysts are recommending an EPS of between $4.02 and $3.72 for the fiscal current year, implying an average EPS of $3.91. EPS for the following year is $4.2, with 6.0 analysts recommending between $4.66 and $3.72.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 6 analysts. It ranges from a high estimate of $2.76B to a low estimate of $2.66B. The current estimate, Bausch Health Companies Inc’s year-ago sales were $2.56BFor the next quarter, 6 analysts are estimating revenue of $2.42B. There is a high estimate of $2.44B for the next quarter, whereas the lowest estimate is $2.41B.
A total of 6 analysts have provided revenue estimates for BHC’s current fiscal year. The highest revenue estimate was $10.23B, while the lowest revenue estimate was $10.13B, resulting in an average revenue estimate of $10.18B. In the same quarter a year ago, actual revenue was $9.62BBased on 6 analysts’ estimates, the company’s revenue will be $10.52B in the next fiscal year. The high estimate is $10.77B and the low estimate is $10.08B.
